Correlation Between Acrivon Therapeutics, and Aadi Bioscience

Can any of the company-specific risk be diversified away by investing in both Acrivon Therapeutics, and Aadi Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acrivon Therapeutics, and Aadi Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Acrivon Therapeutics, Common and Aadi Bioscience, you can compare the effects of market volatilities on Acrivon Therapeutics, and Aadi Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acrivon Therapeutics, with a short position of Aadi Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acrivon Therapeutics, and Aadi Bioscience.

Diversification Opportunities for Acrivon Therapeutics, and Aadi Bioscience

-0.48

Correlation Coefficient

Acrivon Therapeutics,  Aadi Bioscience

Very good diversification

The 3 months correlation between Acrivon and Aadi is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Acrivon Therapeutics, Common and Aadi Bioscience in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aadi Bioscience and Acrivon Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acrivon Therapeutics, Common are associated (or correlated) with Aadi Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aadi Bioscience has no effect on the direction of Acrivon Therapeutics, i.e., Acrivon Therapeutics, and Aadi Bioscience go up and down completely randomly.

Pair Corralation between Acrivon Therapeutics, and Aadi Bioscience

Given the investment horizon of 90 days Acrivon Therapeutics, Common is expected to under-perform the Aadi Bioscience. In addition to that, Acrivon Therapeutics, is 1.51 times more volatile than Aadi Bioscience. It trades about -0.02 of its total potential returns per unit of risk. Aadi Bioscience is currently generating about 0.19 per unit of volatility. If you would invest  174.00  in Aadi Bioscience on September 3, 2024 and sell it today you would earn a total of  60.00  from holding Aadi Bioscience or generate 34.48% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Acrivon Therapeutics, Common  vs.  Aadi Bioscience

Acrivon Therapeutics,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Acrivon Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Acrivon Therapeutics, is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Aadi Bioscience

Risk-Adjusted Performance

15 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Aadi Bioscience are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak fundamental indicators, Aadi Bioscience demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Acrivon Therapeutics, and Aadi Bioscience

The main advantage of trading using opposite Acrivon Therapeutics, and Aadi Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acrivon Therapeutics, position performs unexpectedly, Aadi Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aadi Bioscience will offset losses from the drop in Aadi Bioscience's long position.

The idea behind Acrivon Therapeutics, Common and Aadi Bioscience pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.